US Patent Issued to Corvus Pharmaceuticals on July 21 for "Compounds and methods for modulating interleukin-2-inducible t-cell kinase" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,677, issued on July 21, was assigned to Corvus Pharmaceuticals Inc. (South San Francisco, Calif.).

"Compounds and methods for modulating interleukin-2-inducible t-cell kinase" was invented by Ryan Hudson (San Jose, Calif.) and Anne-Marie Beausoleil (San Mateo, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein, inter alia, are methods and compounds for modulating Interleukin-2-inducible T-cell kinase."

The patent was filed on Feb. 12, 2024, under Application No. 18/439,695.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetah...